Health Affairs

Health Affairs, 23, no. 1 (2004): 23-33 doi: 10.1377/hlthaff.23.1.23 © 2004 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Croghan, T. W. Articles by Pittman, P. M. Search for Related Content PubMed PubMed Citation Articles by Croghan, T. W. Articles by Pittman, P. M. Related Collections Pharmaceuticals Research And Technology Politics

Industry Priorities

The Medicine Cabinet: What’s In It, Why, And Can We Change The Contents?

Thomas W. Croghan and Patricia M. Pittman

The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry’s output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

                      What's this?